Form 4 for WHWK Whitehawk Therapeutics, Inc.
Accepted 2021-07-02 00:00:00 ET · period of report 2021-06-30 · accession 0000899243-21-027290 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-02 | 2021-06-30 | WHWK | Prelack Steven | Dir | A - Grant | $1.52 | +12.3K | 24.5K | +102% | +$18.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-30 | A | A | 12,334 | $1.52 | 24,485 | D | — | — | (F1) Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended June 30, 2021. |